Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VIGABATRIN vs VIMSELTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VIGABATRIN vs VIMSELTINIB: Safety Overview

Metric VIGABATRIN VIMSELTINIB
Total FAERS Reports 12,059 170
Deaths Reported 1,091 0
Death Rate 9.0% N/A
Hospitalizations 3,607 5
Average Patient Age 9.8 yrs 45.6 yrs
% Female Patients 49.0% 55.4%
FDA Approval Date Apr 23, 2018 Feb 14, 2025
Manufacturer Dr. Reddys Laboratories Inc., Deciphera Pharmaceuticals, LLC
Route ORAL ORAL
Marketing Status Prescription Prescription